You're Lightheaded All the Time. Here's the Biological Reason.

MTHFR encodes methylenetetrahydrofolate reductase, an enzyme central to your methylation cycle. This cycle is the metabolic foundation for producing nitric oxide, the molecule that keeps your blood vessels dilated and your brain adequately perfused with oxygen. When methylation runs smoothly, your vascular system maintains the flexibility and responsiveness needed to keep blood flowing to your brain regardless of posture or activity.

The C677T variant, carried by roughly 40% of people of European ancestry, reduces MTHFR enzyme activity by 40 to 70%. With this variant, your cells struggle to produce the tetrahydrofolate needed to synthesize nitric oxide, which means your blood vessels can’t dilate as efficiently in response to the brain’s oxygen demands. The variant is heterozygous in about one third of carriers and homozygous in about one tenth. Homozygous carriers face more significant methylation impairment.

The lived experience is often lightheadedness that worsens when you stand up, a persistent brain fog that feels like low oxygen, and symptoms that improve when you lie down. Your brain is not getting the blood flow it needs, not because your heart is weak or your blood pressure is low, but because your blood vessels don’t have enough nitric oxide to stay properly open. You may also notice a sensitivity to B vitamin supplementation, fatigue that doesn’t match your activity level, and a vague sense of not quite having enough oxygen even when your oxygen saturation is normal.

NOS3 encodes endothelial nitric oxide synthase, the enzyme that produces nitric oxide directly in your blood vessel walls. This is the immediate vascular signaling system that keeps your arteries relaxed and responsive. When NOS3 functions well, your cerebral blood vessels adjust their diameter moment by moment to match your brain’s oxygen needs. When you stand up, your vessels tighten to push blood upward against gravity. When you sit, they relax. This constant recalibration keeps your brain oxygenated and your balance intact.

The Glu298Asp variant, present in roughly 30 to 40% of the population, reduces the amount of functional nitric oxide your endothelial cells produce. Even with normal blood pressure and normal oxygen saturation, your blood vessels produce less of the signaling molecule that keeps them properly dilated, which compromises your cerebral perfusion during positional changes. The effect is often subtle at rest but becomes pronounced when you stand up or change position.

You experience this as a lightheaded feeling that peaks when you transition from lying or sitting to standing, or sometimes as a persistent low-grade dizziness that worsens with activity. Your blood pressure may be fine, but your vascular system can’t recruit enough nitric oxide to maintain adequate brain blood flow during the demands of upright posture. Some people describe it as feeling like their blood can’t quite reach their head when they need it to.

The ACE gene encodes angiotensin-converting enzyme, a central regulator of the renin-angiotensin system. This system controls your blood pressure and vascular tone by producing angiotensin II, a potent vasoconstrictor. When ACE activity is balanced, your blood vessels maintain the precise tone needed to keep blood moving efficiently to your brain without excessive constriction. The system also interacts with nitric oxide to fine-tune vascular function. When ACE goes awry, blood vessel constriction becomes too aggressive or too sluggish, and the balance with nitric oxide is disrupted.

The ACE I/D (insertion/deletion) polymorphism alters the amount of ACE enzyme your cells produce. The D allele is associated with higher enzyme activity and more aggressive angiotensin II production. People homozygous for the D allele or heterozygous D carriers, representing roughly 50 to 60% of the population depending on ancestry, tend to have tighter, more constricted blood vessels. This genetic predisposition toward elevated angiotensin II can exaggerate blood vessel constriction, reduce cerebral blood flow during position changes, and create or worsen lightheadedness, especially when you stand up or exert yourself.

You experience this as dizziness that correlates with your posture, a sensation that your body can’t adequately regulate blood flow to your brain when gravity pulls it downward, and sometimes a feeling of pressure or tightness in your head. The symptom often improves when you lie down and worsens with sustained standing, exercise, or heat exposure. Some people notice that their lightheadedness worsens after meals, when more blood is diverted to digestion.

COMT encodes catechol-O-methyltransferase, the enzyme that degrades dopamine in your brain. Dopamine is not just a molecule of motivation and reward. It’s also central to motor control, postural stability, and the neurological processing that keeps you balanced and oriented in space. When dopamine is recycled too quickly, your brain doesn’t have enough of it to coordinate the precise motor sequences that maintain upright posture and balance.

The Val158Met variant determines how efficiently COMT breaks down dopamine. Roughly 25% of people of European ancestry are homozygous for the slow-metabolizing Met allele, which means their COMT enzyme is less efficient at clearing dopamine from the synapse. People with the slow COMT variant accumulate dopamine, which improves focus and reward processing but can also trigger anxiety, overstimulation, and sometimes a paradoxical feeling of being ungrounded or dizzy when dopamine signaling becomes excessive. Conversely, people with the fast-metabolizing Val allele clear dopamine quickly, which leaves them dopamine-depleted and vulnerable to poor postural control and balance difficulties.

If you have the slow COMT variant (Met/Met), you may notice that stimulants like caffeine, intense stress, or even strong emotions make you lightheaded and dysoriented. Your dopamine is already high, and more input destabilizes your system. If you have the fast variant (Val/Val), you may experience a persistent lightheadedness and a difficulty with proprioception, the sense of where your body is in space. Your dopamine is insufficient to properly support the motor and vestibular circuits that keep you stable.

SLC6A4 encodes the serotonin transporter, a protein that recycles serotonin from the synapse back into neurons so it can be reused. Serotonin profoundly affects mood, but it also regulates the balance between dopamine and other neurotransmitters that control postural stability and vestibular function. When serotonin recycling is efficient, you maintain a stable neurochemical environment. When it’s impaired, serotonin can accumulate and suppress dopamine, disrupting the balance needed for steady balance and orientation.

The 5-HTTLPR variant comes in two main forms: the long allele (L), which allows normal serotonin reuptake, and the short allele (S), which reduces reuptake efficiency. Roughly 40% of the population carries at least one short allele. People with one or two short alleles recycle serotonin more slowly, which can lead to elevated synaptic serotonin that suppresses dopamine activity and impairs the precise neurochemical balance needed for postural control. The result is a feeling of disconnection, lightheadedness, and sometimes a sense of depersonalization when dopamine becomes too suppressed.

You experience this as a persistent dizziness or floating sensation, a feeling that your head is somehow separated from your body, or a lightheadedness that correlates with anxiety or low mood. If you’re on an SSRI (selective serotonin reuptake inhibitor), your symptoms may worsen because the medication further suppresses dopamine. Many people with the short allele report that their balance problems and dizziness worsen when they’re anxious or when serotonin-related mood symptoms flare. The lightheadedness is real and neurochemical, not psychological.

VDR encodes the vitamin D receptor, the protein that makes vitamin D biologically active in your cells. Vitamin D is far more than a bone health molecule. It regulates immune function, neuroinflammation, and the stability of your vestibular system. When your VDR works efficiently, your cells can use even modest amounts of vitamin D to maintain immune tolerance and prevent chronic low-grade inflammation in your nervous system. When VDR function is compromised, you can have adequate vitamin D blood levels and still be functionally deficient at the cellular level.

The FokI polymorphism creates two versions of the VDR protein: the short form (f), which is more transcriptionally active and more efficient, and the long form (F), which is less efficient. Roughly 50% of the population carries at least one copy of the less efficient long form. People with the long form (FF genotype) require more vitamin D to achieve the same cellular effects, and without adequate dosing, they remain functionally deficient, which permits chronic neuroinflammation and vestibular instability. This is a threshold effect: your blood level of vitamin D may be adequate, but your cells aren’t efficiently using it.

You experience this as a persistent lightheadedness that improves when you’re in the sun or on high-dose vitamin D supplementation, or as a dizziness that is worse in winter or in climates with limited sunlight. You may also notice that your immune system is hyperactive, you catch infections easily, or you have unexplained inflammatory responses. Your vestibular system lacks the neuroimmune stability that vitamin D provides, leaving you vulnerable to the low-grade inflammation that triggers balance and dizziness symptoms.